As Of June 30, 2024, BioLineRx Had Cash, Cash Equivalents, And Short-term Bank Deposits Of $40.1M Expected To Be Sufficient To Fund Operations, As Currently Planned, Into 2025
As Of June 30, 2024, BioLineRx Had Cash, Cash Equivalents, And Short-term Bank Deposits Of $40.1M Expected To Be Sufficient To Fund Operations, As Currently Planned, Into 2025
截至2024年6月30日，BioLineRx的現金、現金等價物和短期銀行存款爲4010萬美元，預計足以支持公司的運營，按照當前計劃，可延續至2025年。
As Of June 30, 2024, BioLineRx Had Cash, Cash Equivalents, And Short-term Bank Deposits Of $40.1M Expected To Be Sufficient To Fund Operations, As Currently Planned, Into 2025
截至2024年6月30日，BioLineRx的現金、現金等價物和短期銀行存款爲4010萬美元，預計足以支持公司的運營，按照當前計劃，可延續至2025年。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間